EBV-LMP1 targeted DNAzyme
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EBV-LMP1 targeted DNAzyme, covering 2011-10-10 to 2011-10-10. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma [Phase 1, Phase 2]